Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:04:04 EST Sun 08 Nov 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 26 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-11-08 16:55U:ELEKNews ReleasePenny Stock Lovers, Microcap Investors: This Is Your Time To Shine
2026-11-08 16:45U:VIRNews ReleaseVir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data
2026-11-08 16:35U:MLYSNews ReleaseMineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026
2026-11-08 16:23U:ELEKNews ReleaseMicrocap Investors, Penny Stock Enthusiasts: Your Time To Shine May Be Now
2026-11-08 16:15U:VIRNews ReleaseVir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta
2026-11-08 16:01U:RDNTNews ReleaseRadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
2026-11-08 16:00U:REGNNews ReleaseCIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD
2026-11-08 15:33U:ELEKNews ReleaseTime Is of the Essence: Elektros Advances Development Efforts for Its Patented Multi-Port EV Charging Technology
2026-11-08 15:30U:RCELNews ReleaseAVITA Medical to Host Investor Webinar Briefing
2026-11-08 15:00U:NVDANews ReleaseStatement from NVIDIA Board of Directors
2026-11-08 12:45U:ABBVNews ReleaseAllergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
2026-11-08 11:00U:JNJNews ReleaseJohnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer
2026-11-08 10:30U:CRSPNews ReleaseCRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
2026-11-08 10:30U:CGEMNews ReleaseVelinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026
2026-11-08 10:00U:CABANews ReleaseCabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases
2026-11-08 04:56U:TZOONews ReleaseClub Offers for Travel Enthusiasts in Germany
2026-11-08 03:00U:TZOONews ReleaseClub Offers for Travel Enthusiasts in Canada
2026-11-08 00:00U:TZOONews ReleaseClub Offers for Travel Enthusiasts in the U.S.
2026-11-07 19:47U:ELEKNews ReleaseElektros, Inc. (OTC:ELEK) Celebrates Moishe Mana's $1.1 Billion Wynwood Milestone - a Landmark Moment for Miami
2026-11-07 19:28U:UHALNews ReleaseNorth Georgia Flooding: U-Haul Offers 30 Days Free Storage at 14 Stores
2026-11-07 19:07U:ELEKNews ReleaseElektros, Inc. (OTC:ELEK) Congratulates Moishe Mana on a Defining Wynwood Achievement and a New Chapter for Miami
2026-11-07 19:01U:TZOONews ReleaseClub Offers for Travel Enthusiasts in the UK
2026-11-07 18:46U:ELEKNews ReleaseElektros, Inc. (OTC:ELEK) Celebrates Moishe Mana's Landmark Wynwood Achievement - a $1.1 Billion Milestone for Miami's Future
2026-11-07 18:00U:VOYGNews ReleaseVoyager Awarded NASA CLPS 2 Contract
2026-11-07 17:55U:FLYNews ReleaseFirefly Aerospace Selected as a Vendor for NASA's $10 Billion CLPS 2 Initiative
2026-11-07 17:54U:SUNXFNews ReleaseStardust Appoints Eamonn McHugh as CEO in Strategic Leadership Transition